Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Research Article

Efficient Synthesis of Ibandronate in the Presence of an Ionic Liquid

Author(s): David Illes Nagy, Alajos Grun, Oliver Pavela, Sandor Garadnay, Istvan Greiner and Gyorgy Keglevich*

Volume 15, Issue 7, 2018

Page: [713 - 720] Pages: 8

DOI: 10.2174/1570180814666171027160324

Abstract

Background: Ibandronate is a prominent representative of α-hydroxymethylenebisphosphonic acid (dronic acid) derivatives applied in the treatment of bone diseases.

Methods: Ibandronate was synthesized from N-methyl-N-pentyl-β-alanine using phosphorus trichloride and phosphorous acid in different ratios, applying sulfolane as the solvent (1.), or under solvent-free conditions (2.), or in ionic liquids as additives (3.).

Results: In the first two cases (1. and 2.), using phosphorus trichloride and phosphorous acid in molar ratios of 2:4 and 3:4, pure ibandronate was obtained in yields of 72-83%. In the presence of 10% of [bmim][BF4] as an additive (3.), a better yield of 82/90% was obtained applying ratios of 2:2 and 3:2 of the P-reagents assuming less of the phosphorous acid.

Conclusion: The new methods developed mean record outcomes in respect of the valuable drug, ibandronate.

Keywords: Ibandronate, N-methyl-N-pentyl-β-alanine, P-reagents, sulfolane, ionic liquid additive, osteoporosis.

Graphical Abstract

© 2022 Bentham Science Publishers | Privacy Policy